No Regional Disparities in Sofosbuvir Plus Ribavirin Therapy for HCV Genotype 2 Infection in Tochigi Prefecture and Its Vicinity

OBJECTIVE: Regional disparities were observed in the outcomes of interferon (IFN)-based therapy for chronic hepatitis C virus (HCV) infection in a Japanese nationwide study. However, whether or not these regional disparities are observed in the outcomes of direct-acting antiviral drugs, including so...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirosawa, Takuya, Morimoto, Naoki, Miura, Kouichi, Tahara, Toshiyuki, Murohisa, Toshimitsu, Okamura, Yukishige, Sato, Takashi, Numao, Norikatsu, Imai, Masato, Tano, Shigeo, Murayama, Kozue, Kurata, Hidekazu, Ozawa, Iwao, Fukaya, Yukimura, Yoshizumi, Hiroaki, Watanabe, Shunji, Tsukui, Mamiko, Takaoka, Yoshinari, Nomoto, Hiroaki, Isoda, Norio, Yamamoto, Hironori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421161/
https://www.ncbi.nlm.nih.gov/pubmed/30333396
http://dx.doi.org/10.2169/internalmedicine.1194-18

Ejemplares similares

Ejemplares similares